Jiangzhong Pharmaceutical Co Ltd600750
▼ NegativeCapitalrelevance
First-half net profit fell 5.92% year on year, with revenue down 9.75%.

China Resources Jiangzhong disclosed its 2026 semi-annual report. In the first half, total operating revenue was 1.932 billion yuan, down 9.75 percent year on year. Net profit attributable to the parent was 491 million yuan, down 5.92 percent. Non-GAAP net profit was 470 million yuan, down 2.59 percent. The company plans a cash dividend of 5 yuan per 10 shares, tax included. Net cash flow from operating activities was 696 million yuan, up 6.80 percent year on year. Basic earnings per share were 0.78 yuan, and the weighted average return on equity was 11.51 percent.
Jiangzhong Pharmaceutical Co LtdFirst-half net profit fell 5.92% year on year, with revenue down 9.75%.